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Abstract
A functional 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway is required for isoprenoid biosynthesis and hence survival
in Escherichia coli and most other bacteria. In the first two steps of the pathway, MEP is produced from the central metabolic
intermediates pyruvate and glyceraldehyde 3-phosphate via 1-deoxy-D-xylulose 5-phosphate (DXP) by the activity of the
enzymes DXP synthase (DXS) and DXP reductoisomerase (DXR). Because the MEP pathway is absent from humans, it was
proposed as a promising new target to develop new antibiotics. However, the lethal phenotype caused by the deletion of
DXS or DXR was found to be suppressed with a relatively high efficiency by unidentified mutations. Here we report that
several mutations in the unrelated genes aceE and ribB rescue growth of DXS-defective mutants because the encoded
enzymes allowed the production of sufficient DXP in vivo. Together, this work unveils the diversity of mechanisms that can
evolve in bacteria to circumvent a blockage of the first step of the MEP pathway.
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Introduction
Isoprenoids (also called terpenoids) are a ubiquitous and highly
diverse family of compounds produced from the five-carbon
precursor isopentenyl diphosphate (IPP) and its double-bond
isomer dimethylallyl diphosphate (DMAPP) in all living organisms
[1–3]. These precursors are synthesized from acetyl-CoA by the
mevalonic acid (MVA) pathway in archaea (archaebacteria), fungi,
and animals. By contrast, the unrelated 2-C-methyl-D-erythritol 4-
phosphate (MEP) pathway produces IPP and DMAPP from
pyruvate and glyceraldehyde 3-phosphate in most bacteria
(eubacteria) and apicomplexan protozoa, including important
human pathogens such as those causing tuberculosis and malaria
[3–5]. Because the MEP pathway is essential in such pathogens
but is not present in animals, it has been proposed as a promising
target for the design of new antibacterial and antimalarial agents
that would be potentially innocuous for humans [6–8]. However,
we still know little about possible mechanisms of resistance to
current and potential drugs targeting the MEP pathway in
bacterial pathogens.
The genes and enzymes of the MEP pathway are best
characterized in Escherichia coli. The initial reaction of the pathway
(Fig. 1) is catalyzed by 1-deoxy-D-xylulose 5-phosphate (DXP)
synthase (DXS, encoded by the dxs gene) and involves the
condensation of (hydroxyethyl)thiamine, derived from pyruvate,
with the C1 aldehyde group of D-glyceraldehyde 3-phosphate to
produce DXP [9–11]. In the second step, an intramolecular
rearrangement and reduction of DXP by the enzyme DXP
reductoisomerase (DXR, encoded by the ispC/yaeE/dxr gene)
yields MEP [12,13]. An alternative oxidoreductase enzyme with
a DXR-like (DRL) activity was recently found in a reduced
number of bacteria [14]. MEP produced by DXR or DRL is
eventually converted to both IPP and DMAPP by sequential
activities of the enzymes encoded by the genes ispD/ygbP, ispE/
ychB, ispF/ygbP, ispG/gcpE, and ispH/lytB [5,15].
The best studied inhibitor of the MEP pathway is fosmidomycin
(FSM), a specific inhibitor of the enzyme DXR which also inhibits
DRL [14,16–19]. The uptake of FSM by bacterial cells is an active
process involving a cAMP-dependent glycerol 3-phosphate trans-
porter (GlpT) protein [20]. Loss of GlpT activity in E. coli mutants
or the absence of a GlpT homologue in other bacteria such as
Mycobacterium tuberculosis or Brucella abortus leads to FSM resistance
[14,20,21]. Enhanced export of the inhibitor by overexpression of
the E. coli fsr gene also results in FSM resistance [22]. Antibiotic
resistance can result not only from interfering with drug transport
or mode of action but also from the use of an alternative pathway
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not affected by the inhibitor. To investigate the relevance of the
latter type of mechanisms for resistance to MEP pathway
inhibitors, we aimed to identify spontaneous mutations that could
suppress an otherwise lethal obstruction of the pathway in living
bacteria.
Loss of function of the MEP pathway in E. coli can be rescued in
strains containing a synthetic MVA operon that allows the
production of IPP and DMAPP from exogenously supplied
MVA (Fig. 1) [23,24]. However, in cells harboring a deletion of
the dxs gene (strain EcAB4-2), MVA auxotrophy was suppressed
with a relatively high frequency (6.4 per 109 cells) by mutations in
other genes [25]. As a result, colonies of DXS-defective suppressor
mutants could grow overnight on plates lacking MVA. Suppressor
mutants were also found in the DXR-deficient strain EcAB4-10,
although with a slightly lower frequency (2.4 per 109 cells) and
poor growth. No suppressor mutants were found in strains with
disruptions to the other MEP pathway genes [25]. These results
suggested that bacteria can respond to a block of DXS or DXR
activities by using other proteins that deliver DXP or MEP when
mutated [25]. In this work we identify genes and mutations that
allow survival of DXS-deficient strains and demonstrate that the
mutant proteins are indeed able to synthesize DXP (or a precursor
molecule) in vivo.
Materials and Methods
Bacterial strains and screening for suppressor mutants
Disruption of individual MEP pathway genes in E. coli strains
EcAB4-2 (dxs::CAT) and EcAB4-10 (dxr::CAT), each containing
a chromosomal copy of a synthetic MVA operon, was carried out
as described [25] by deleting most of their coding region and
introducing chloramphenicol resistance (CAT) genes. Similarly,
strain EcAB1-6 (dxs::CAT dxr::TET) was constructed by disrupting
both dxs and dxr genes with chloramphenicol and tetracycline
resistance genes, respectively, in MC4100 cells harboring the
MVA operon in plasmid pAB-M3 [23,26]. For isolation of
suppressor mutants, EcAB4-2 cells were cultured at 37uC in Luria
broth (LB) medium supplemented with 1 mM MVA, 25 mg/ml
kanamycin (to select for the MVA operon) and 17 mg/ml
chloramphenicol (to select for the disruption of the dxs gene) until
exponential phase. After cells were pelleted and rinsed twice with
LB, several batches of ca.108 cells (estimated by measuring optical
density at 600 nm, OD600) were plated on LB agar containing
only kanamycin and chloramphenicol. In some plates, a paper disk
soaked in 30 ml ethylmethane sulphonate (EMS) was placed on the
surface of the medium to induce mutations. Spontaneous and
EMS-induced mutants that formed a colony in the absence of
MVA were analyzed to confirm the deletion of the dxs genes by
PCR.
Identification of the genes mutated in the suppressor
lines
Genomic DNA from suppressor mutants was isolated as
described [25,27] and partially digested with Sau3A. Fragments
of 2–4 kb were gel-purified using the Qiaquick (Qiagen) system
and ligated into the BamHI site of pUC19. After amplification of
the genomic library in TOP10 cells, EcAB4-2 competent cells
were transformed with aliquots of the library, and transformants
resistant to kanamycin, chloramphenicol, and 100 mg/ml ampi-
cillin that were able to grow without MVA were selected. Plasmid
DNA isolated from these transformants was used to transform new
EcAB4-2 cells to confirm that it conferred the ability to grow in the
absence of MVA. Positive clones were sequenced to identify the
gene (and the mutation) responsible for the suppression phenotype.
Screenings for mutations specifically in aceE and ribB were carried
out by amplification of their coding regions by colony PCR with
high-fidelity AccuPrime DNA polymerase (Invitrogen), followed
by sequencing.
Plasmid constructs
The wild-type and mutant aceE and ribB genes (including the
promoter region) were amplified from EcAB4-2 and suppressor
mutant cells by PCR using AccuPrime DNA polymerase and
primers aceE-1F (59- C C A G A A G A T G T T G T A A A T C
A A G C -39) and aceE-4R (59- T T T A C C T C T T A C G C C
A G A C G -39) for aceE and ribB-pNF (59- A G C A T A T G A G
T G C C A T T G T A G T G-39) and ribB-XR (59- A G T C A C
T C G A G G C T G G C T T T A C G C T C A T G T G C-39)
for ribB. The PCR products were gel-purified and cloned into
pCRII-TOPO (Invitrogen). Inserts were sequenced using vector
and gene-specific primers to confirm the presence of the identified
mutations.
Figure 1. Biosynthesis of isoprenoid precursors in E. coli. The
indicated genes (in italics) encode enzymes that produce the first
intermediates of the MEP pathway either originally (dxs, dxr) or by
mutation as indicated by asterisks (aceE, ribB). The E. coli strains used in
this work are engineered to synthesize isopentenyl diphosphate (IPP)
and dimethylallyl diphosphate (DMAPP) from exogenously supplied
mevalonic acid (MVA). GAP, D-glyceraldehyde 3-phosphate; DXP, 1-
deoxy-D-xylulose 5-phosphate; MEP, 2-C-methyl-D-erythritol 4-phos-
phate.
doi:10.1371/journal.pone.0043775.g001
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Detection of DXP in cell extracts
EcAB1-6 cells were transformed with plasmids harboring wild
type and mutant versions of aceE or ribB (or an empty pCRII-
TOPO plasmid as a control) and positive transformants were
selected on LB plates supplemented with 1 mM MVA, 50 mg/ml
kanamycin (to select for the pCRII-TOPO constructs), 100 mg/ml
ampicillin (to select for the pAB-M3 plasmid with the MVA
operon), 17 mg/ml chloramphenicol (to select for the disruption of
the dxs gene), and 5 mg/ml tetracyclin (to select for the disruption
of the dxr gene). Individual colonies were then grown at 37uC
overnight in liquid media with the same supplements. The
overnight cultures were used to confirm the identity of the strain
and plasmids by PCR and restriction analysis and to inoculate
fresh 10 ml cultures to an OD600 of 0.05. Inoculated cultures
were grown at 37uC for 5 hours and aliquots corresponding to an
OD600 of 10 were then collected. Cells were pelleted and
immediately resuspended in 200 ml of 1:1 (v/v) methanol: water.
Cell suspensions were loaded in Amicon Ultra-0.5 centrifugal filter
devices and spun at 14,000 rpm and 4uC for 90 min in
a refrigerated microfuge. DXP was detected and quantified in
the flow-through by liquid chromatography and mass spectrom-
etry (LC-MS).
LC was conducted on an ZIC-pHILIC column of 150-mm
length, 2.1-mm internal diameter, and 5-mm particle size (Merck
SeQuant), using an Agilent 1200 Series HPLC system. A sample
injection volume of 2 mL was used throughout. The temperature
of the sample tray was maintained at 4uC by an Agilent FC/ALS
Thermostat. The column compartment was set to 50uC. The
mobile phases used were composed of A) 80 mM ammonium
carbonate and B) acetonitrile. Isocratic elution was achieved at
68% B via a flow rate of 0.23 mL/min for 12 min. From there the
flow rate was gradually increased to 0.3 mL/min until 12.5 min.
The flow rate was then held at 0.3 mL/min for a further 2.5 min.
The HPLC system was coupled to an Agilent 6210 time-of-flight
mass spectrometer (LC-TOF MS), by a 1/3 post-column split.
Contact between both instrument set-ups was established by
a LAN card in order to trigger the MS into operation upon the
initiation of a run cycle from the MassHunter workstation
(Agilent). Nitrogen gas was used as both the nebulizing and
drying gases to facilitate the production of gas-phase ions. The
drying and nebulizing gases were set to 10 L/min and 25 psi,
respectively, and a drying gas temperature of 300uC was used
throughout. Electrospray ionization (ESI) was conducted in the
negative ion mode and a capillary voltage of –3500 V was utilized.
MS experiments were carried out in the full scan mode, at
0.86 spectra/ sec and a cycle time of 1.1162.8 sec, for the
detection of [M–H]- ions. The instrument was tuned for a range of
50–1700 m/z. Prior to LC-ESI-TOF MS analysis, the TOF MS
was calibrated via an ESI-L-low concentration tuning mix
(Agilent). Data acquisition and processing were performed by
the MassHunter software package. DXP was quantified via a five-
point calibration curve. The R2 coefficient for the calibration
curve was .0.99. The chemical standard for DXP (Echelon) was
made up to 500 mM, as the stock solution, in methanol-water
(50:50, v/v).
Results
Most DXS-defective suppressor mutants harbour
mutations in the aceE gene
To investigate the mechanisms by which bacteria could survive
in the absence of a DXS enzyme, we aimed to identify the genes
responsible in a collection of DXS-defective suppressor mutants
(SX lines). Previous screening for suppressors of MVA auxotrophy
in DXS-defective EcAB4-2 cells (i.e. the lethality caused by dxs
deletion) resulted in the isolation of 6 spontaneous mutants (SX1 to
SX6) [25]. A second screening led to the isolation of 14 more
spontaneous mutants (SX7 to SX20) and 14 EMS-induced
mutants (SX1E to SX14E). However, 6 spontaneous mutants
and 2 EMS-induced mutants lost the ability to grow without MVA
after storage as glycerol stocks and re-streaking on fresh LB plates
supplemented only with kanamycin and ampicillin. Of the
remaining 26 mutants, one (SX5) was previously reported to
harbor a missense mutation in the aceE gene (encoding the
catalytic E1 subunit of the pyruvate dehydrogenase complex,
PDH), resulting in an E636Q change in the protein sequence [25].
Sequencing of the aceE gene in the remaining mutants identified
a total of 4 different mutations (Table 1). In particular, the E636Q
mutation was found in 2 other strains besides SX5, whereas 1
clone had a different mutation in the same residue (E636G). Two
more aceE mutations were found: Q408R in 1 strain and L633R in
17 clones. In total, 22 out of 26 suppressor SX mutants contained
mutations in the aceE gene, suggesting that the alteration of PDH
activity might be the most common mechanism of resistance to the
inhibition of DXS activity.
A mutant ribB gene was found in the remainder of the
DXS-deficient suppressors
To identify the genetic change responsible for the bypass of
DXS activity in the 4 remaining strains with no mutations in aceE
(SX6, SX7, SX18, and SX12E), we followed a strategy similar to
that previously described for SX5 [25]. We selected strain SX18 to
construct a genomic library in pUC19. After amplification, DXS-
defective EcAB4-2 cells were transformed with the library, and
colonies able to grow without MVA were selected to isolate the
incorporated plasmid and sequence the corresponding inserts. All
the isolated plasmids were found to contain a mutation in the ribB
gene, encoding 3,4-dihydroxy-2-butanone 4-phosphate synthase
(DHBPS). This enzyme catalyzes the conversion of D-ribulose 5-
phosphate to formate and 3,4-dihydroxy-2-butanone 4-phosphate,
the latter serving as the biosynthetic precursor for the xylene ring
of riboflavin [28]. Complete sequencing of the ribB gene in strains
SX6, SX7 and SX12E also found mutations in this gene. In
particular, a missense mutation resulting in a G108S change in
DHBPS was found in SX18 and SX12E, whereas clones SX6 and
SX7 harbored a D113G change (Table 1).
The identified mutations are sufficient to rescue the loss
of DXS activity in EcAB4-2 cells
To confirm whether the new mutations identified in aceE and
ribB were actually responsible for the suppression phenotype, wild
type and mutant versions of these genes (including their promoters)
Table 1. Ocurrence of identified mutations in EcAB4-2 cells.
Mutation Ocurrence
Gene DNA Protein (# strains)
aceE cag . cgg Q408R 1
ctg . cgg L633R 17
gaa . caa E636Q 3
gaa . gga E636G 1
ribB ggt . agt G108S 2
gac . ggc D113G 2
doi:10.1371/journal.pone.0043775.t001
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were amplified from the parental EcAB4-2 strain and the
corresponding suppressor mutants, respectively, and used to
complement EcAB4-2 cells. As shown previously [25], the plasmid
carrying the E636Q mutation in aceE rescued growth on plates
without MVA, whereas the wild type gene did not complement the
loss of DXS activity in EcAB4-2 (Fig. 2). The other aceE mutations
(Q408R, L633R, and E636G) were also able to rescue MVA
auxotrophy of the strain. Similarly, the two identified mutant
forms of ribB (G108S and D113G), but not the wild type version,
rescued growth of DXS-defective EcAB4-2 cells in medium
without MVA (Fig. 2). These results suggest that the presence of
any of the identified mutations in aceE or ribB results in altered
enzymes (PDH or DHBPS, respectively) that each produce
a metabolite that can ultimately be converted to isoprenoids in
the absence of a functional DXS activity.
Mutant aceE and ribB genes allow the production of DXP
in vivo
The bypass of DXS by mutant forms of PDH and DHBPS
enzymes might result either from the production of DXP or an
alternative substrate for DXR, or from the supply of MEP or
a downstream metabolite of the pathway (Fig. 1). The latter
possibility can be addressed by using a genetic strategy based on
the complementation of the DXR-deficient strain EcAB4-10.
Thus, the putative production of MEP or a downstream MEP
pathway intermediate by the mutant enzymes would allow not
only DXS-defective but also DXR-defective cells to grow in the
absence of MVA (Fig. 1). However, when EcAB4-10 cells were
transformed with the constructs containing mutant aceE and ribB
genes, transformants could only be recovered on MVA-containing
plates because none of them were able to rescue MVA auxotrophy
(Fig. 2). These results confirm that the mutant PDH and DHBPS
enzymes synthesize a product that enters the MEP pathway
upstream of the reaction catalyzed by DXR.
To discriminate between the remaining possibilities (i.e. the
mutant enzymes allow the production of either DXP or another
metabolite that can be used as an alternative substrate for DXR),
we investigated whether the presence of mutant versions of PDH
or DHBPS resulted in the production of DXP in cells lacking both
DXS and DXR activities (strain EcAB1-6). After transformation of
the EcAB1-6 strain with plasmids containing wild type and mutant
versions of both aceE and ribB, cells were grown in MVA-
supplemented liquid medium and harvested in the exponential
growth phase. HPLC-MS/MS analysis of cell extracts from
controls transformed with an empty plasmid showed the presence
of low but detectable levels of DXP (Fig. 3), indicating that E. coli
cells devoid of DXS activity can still produce trace amounts of this
metabolite. Levels of DXP in transformants carrying plasmids with
wild type versions of aceE or ribB genes were similar to those in the
negative control. By contrast, strains expressing the mutant genes
showed ca. 20-fold higher DXP levels (Fig. 3), confirming that the
corresponding mutant enzymes are able to synthesize DXP (or
a metabolite that can be transformed into DXP by the cells) in vivo.
Discussion
In bacteria, isoprenoids play essential roles in a variety of
processes that are vital for growth and survival, including cell wall
and membrane biosynthesis, electron transport, and conversion of
light into chemical energy [29]. Also, many microorganisms
produce isoprenoid secondary metabolites of economic relevance
[30]. Since the discovery of the MEP pathway in the mid 1990 s, it
became more and more evident that bacteria display a wide
metabolic plasticity regarding the route to produce isoprenoids.
Most bacteria only use the MEP pathway for IPP and DMAPP
biosynthesis, but there are exceptions to this trend. Some bacteria
synthesize their isoprenoid precursors using the MVA pathway
instead of the MEP pathway, whereas there are parasitic bacteria
Figure 2. Complementation of E.coli strains defective in DXS or
DXR. Cells were transformed with pCRII-TOPO constructs and plated on
LB medium containing chloramphenicol (for the disruption of
chromosomal dxs or dxr genes), kanamycin (for the MVA operon) and
ampicillin (for the introduced plasmid). The medium was supplemented
(+) or not (2) with MVA as indicated. Plates were incubated at 37uC for
20 h. (A) Position of transformants harboring plasmids with the
indicated wild type or mutant (asterisks) genes or an empty vector
control (Ø). (B) EcAB4-2 (dxs::CAT) transformants. (C) EcAB4-10 (dxr::CAT)
transformants.
doi:10.1371/journal.pone.0043775.g002
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that lack both pathways (likely because they obtain their
isoprenoids from host cells) and also organisms that possess the
two full pathways [3,31–34]. Most strikingly, related bacteria may
use different pathways for isoprenoid biosynthesis while unrelated
bacteria may use the same pathway. In addition to the MEP and
MVA pathways, alternative pathways and metabolic intermediates
have been proposed for isoprenoid biosynthesis in the cyanobac-
terium Synechocystis PCC 6803, which lacks the MVA pathway and
does not appear to use the canonical MEP pathway under
photosynthetic conditions [35,36]. Diversity can be found also at
the level of individual pathway steps, with several examples of
reactions catalyzed by different classes of enzymes with no
sequence, structural, or catalytic similarity [14,17,33,37]. In at
least some cases, it is clear that the alternative routes to MEP
pathway intermediates resulted from the recruitment of available
enzymes that were not related to isoprenoid synthesis. But we still
know very little about the genes and enzymes that could
potentially contribute to isoprenoid biosynthesis, despite the
relevance of this knowledge to both development of efficient
antibiotics and metabolic engineering of isoprenoid biosynthesis.
Here we show that the MEP pathway intermediate DXP can be
produced (although at very low levels) in the absence of
a functional DXS-encoding gene, suggesting that other enzymes
might produce this metabolite, perhaps as a by-product. However,
such trace levels are not sufficient to support bacterial growth and
survival. We also provide biochemical and genetic evidence of
novel routes for efficient DXP synthesis arising from specific
mutations in two E. coli genes, aceE and ribB (encoding PDH and
DHBPS, respectively).
The E636Q mutation in PDH was previously shown to rescue
the deficiency of DXS but not DXR activity in vivo [25]. In this
work, we have identified three more mutations (Q408R, L633R,
and E636G) that allow PDH to catalyze an unknown reaction that
eventually results in the production of DXP in the absence of
endogenous DXS activity. Like DXS, PDH is a thiamine di-
phosphate (TPP) dependent carboligase that catalyzes the de-
carboxylation of pyruvate with the formation of hydroxyethyl-TPP
as an intermediate. In fact, purified PDH has been shown to
catalyze the formation of 1-deoxy-D-xylulose (DX) from pyruvate
and D-glyceraldehyde [38,39]. DX can be phosphorylated to
DXP by the kinase encoded by the xylB gene in E. coli [40].
However, our results suggest that in vivo the wild type PDH
enzyme does not produce enough DX (or DXP, using D-
glyceraldehyde 3-phosphate) to rescue the loss of DXS activity
since only the mutant enzyme is able to complement the dxs
knockout (Fig. 2) and to cause an accumulation of DXP beyond
background levels (Fig. 3).
In the case of DHBPS, the proposed mechanism for the
conversion of D-ribulose 5-phosphate to formate and 3,4-
dihydroxy-2-butanone 4-phosphate involves a complex series of
steps including dehydration, intramolecular rearrangement and
rehydration [41]. Interestingly, the alternative route into the MEP
pathway proposed in Synechocystis PCC 6803 appears to be
stimulated by D-xylulose 5-phosphate and also by dihydroxyac-
etone phosphate [35,36]. We therefore speculate that either D-
ribulose 5-phosphate or its isomer D-xylulose 5-phospate might be
converted to DXP by mutant G108S or D113G enzymes. We
intend to further investigate the metabolic route to the DXP
pathway enabled by mutant DHBPS enzymes using these and
alternative substrates and considering the option that a metabolite
may be generated that serves as an intermediate for DXP
synthesis.
In summary, our work demonstrates that bacteria can
circumvent a blockage of the MEP pathway at the level of DXS
by mutation of either of two genes (aceE and ribB). Based on these
results, DXS is not a good target for the development of new
antibiotics, since resistance is likely to be developed very easily. On
the other hand, DXP production appears to be one of the main
flux-determining steps of the MEP pathway because overexpres-
sion of DXS-encoding genes has been shown to result in an
enhanced production of MEP-derived isoprenoids in bacteria and
plants [30,42]. We are currently investigating whether the use of
mutant PDH and DHBPS enzymes could be a good strategy to
overproduce DXP in metabolic engineering approaches.
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